How much has Decagon raised?

Decagon has raised approximately $481 million in disclosed equity funding across four priced rounds: a $35M Series A (July 2024), a $65M Series B (October 2024), a $131M Series C (June 2025), and a $250M Series D (January 2026). The company has not disclosed any venture debt, revolving credit facility, or revenue-based financing. All rounds have been pure equity with no reported convertible notes bridging between them.

The velocity is remarkable: all four rounds closed within 18 months of Decagon emerging from stealth, averaging more than one priced round per quarter. For context, that pace puts Decagon alongside other hyper-growth enterprise AI companies of the era in terms of capital accumulation speed, though Decagon remains considerably smaller in total raise than infrastructure-layer companies like Anthropic. The March 2026 employee tender offer — at the same $4.5B valuation — confirmed no compression in the months following the Series D and delivered real liquidity to more than 300 employees.

The investor roster reads as a who's-who of enterprise AI mega-funds. Accel and Andreessen Horowitz (a16z) have backed Decagon from the Series A through the Series D, reflecting sustained high conviction across four rounds. Bain Capital Ventures led the Series B and has continued in subsequent rounds — BCV published a thesis post citing the founding team's prior-exit track records and early enterprise deflection metrics above 70% as the primary investment thesis. Elad Gil (early investor in Stripe, Airbnb, and Coinbase) has also participated, adding further individual credibility.

Coatue Management and Index Ventures co-led the $250M Series D. Index's investment memo cited the founding team's 'clock speed' — moving fast without lowering standards — as a primary differentiator. Ribbit Capital (fintech-focused), Forerunner Ventures (consumer and B2B commerce), and Definition Capital (European growth fund) round out the cap table, reflecting Decagon's customer traction across fintech, commerce, and international enterprise verticals. New investors ChemistryVC and Starwood Capital joined the Series D, broadening the base further.

From the Series C ($1.5B, June 2025) to the Series D ($4.5B, January 2026), Decagon's valuation tripled in under seven months. The primary driver was accelerating commercial traction: the company added more than 100 enterprise customers in 2025 alone — including Avis Budget Group, Block, and Deutsche Telekom — validating the ability to move upmarket into F100 accounts. ARR grew more than 3× year-over-year to approximately $35M annualized by October 2025.

Secondary drivers included the broader surge in enterprise AI agent valuations (Sierra AI closed at $15.8B in May 2026, validating the category ceiling), Decagon's transition to proprietary fine-tuned models (by March 2026, ~80% of inference runs on in-house models achieving 6× cost reduction versus closed APIs), the launch of Voice 2.0 with sub-second latency opening a new higher-value product category, and the Spring 2026 Proactive Agents launch introducing outbound AI voice and user memory. The employee tender offer in March 2026 at the same $4.5B price confirmed no valuation compression in the months following the round.

Decagon has not disclosed profitability metrics publicly. At approximately $35M ARR with 434 employees — plus the cost of white-glove enterprise onboarding and dedicated engineering support for each customer — the company is almost certainly not yet EBITDA-positive. However, the deliberate shift to proprietary models reducing inference COGS by approximately 6× signals a structured path toward margin expansion as volume scales.

A public offering has not been announced or guided to. With $481M raised and a $4.5B private valuation, and ARR growing 3×+ year-over-year, a direct listing or traditional IPO is plausible in 2027–2028 if growth continues. The March 2026 employee tender offer provides meaningful interim liquidity, which typically reduces urgency for an IPO among employees and early investors. No acquisition talks have been reported as of June 2026.

Decagon entered 2026 with substantial fresh capital from its $250M Series D and is executing a major office expansion — 69,000 sq ft across two floors at 680 Folsom Street in SoMa, San Francisco. This signals active investment in headcount, tooling, and go-to-market infrastructure, meaning new departmental budgets across engineering, sales, marketing, and customer success are coming online throughout 2026.

For sellers, the practical implications are: (1) Decagon's procurement process is maturing rapidly but is not yet Fortune 500-bureaucratic — deals can move quickly through a relatively small buying committee still centered on the two founders. (2) The Series D investors' involvement in the tender offer means financial sponsors (Coatue, Index) now hold material ownership and care about unit economics — vendors pitching efficiency, ROI, and cost reduction will resonate more than those pitching features alone. (3) As Decagon expands internationally into London and New York, vendors with presence in those markets have structural advantage for field engagement. (4) The shift to in-house AI models signals a strong build-over-buy posture for core AI infrastructure — infrastructure, data, observability, and security vendors have better fit than AI API providers.